ASPIRIN
Clinical trials for ASPIRIN explained in plain language.
Never miss a new study
Get alerted when new ASPIRIN trials appear
Sign up with your email to follow new studies for ASPIRIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: ASPIRIN
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a different aspirin regimen better protect diabetic hearts?
Disease control Recruiting nowThis study looks at whether changing the dose or form of aspirin can improve blood clotting control in people with type 2 diabetes who don't respond well to standard enteric-coated aspirin. About 30 participants will try three different aspirin regimens over several weeks. The ma…
Matched conditions: ASPIRIN
Phase: PHASE1 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a daily aspirin save mothers and babies from hypertension risks?
Prevention Recruiting nowThis study tests whether taking 150 mg of aspirin daily, starting before 20 weeks of pregnancy, can prevent serious problems like preeclampsia, poor fetal growth, placental abruption, preterm birth, and death in pregnant women with chronic high blood pressure. About 500 women wil…
Matched conditions: ASPIRIN
Phase: PHASE3 • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC